TY - JOUR AU - Abel, T. PY - 2009 DA - 2009// TI - Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease JO - Med Sci Monit VL - 15 ID - Abel2009 ER - TY - JOUR AU - Duvnjak, M. PY - 2009 DA - 2009// TI - Therapy of nonalcoholic fatty liver disease: current status JO - J Physiol Pharmacol VL - 60 ID - Duvnjak2009 ER - TY - JOUR AU - Kaser, S. AU - Ebenbichler, C. F. AU - Tilg, H. PY - 2010 DA - 2010// TI - Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease JO - Int J Clin Pract VL - 64 UR - https://doi.org/10.1111/j.1742-1241.2009.02327.x DO - 10.1111/j.1742-1241.2009.02327.x ID - Kaser2010 ER - TY - JOUR AU - Catta-Preta, M. PY - 2011 DA - 2011// TI - A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies JO - Virchows Arch VL - 459 UR - https://doi.org/10.1007/s00428-011-1147-1 DO - 10.1007/s00428-011-1147-1 ID - Catta-Preta2011 ER - TY - JOUR AU - Hyogo, H. PY - 2008 DA - 2008// TI - Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia JO - Metabolism VL - 57 UR - https://doi.org/10.1016/j.metabol.2008.07.030 DO - 10.1016/j.metabol.2008.07.030 ID - Hyogo2008 ER - TY - JOUR AU - Souza-Mello, V. PY - 2010 DA - 2010// TI - Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet JO - Clin Sci (Lond) VL - 119 UR - https://doi.org/10.1042/CS20100061 DO - 10.1042/CS20100061 ID - Souza-Mello2010 ER - TY - JOUR AU - Vijan, S. AU - Hayward, R. A. PY - 2004 DA - 2004// TI - Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians JO - Ann Intern Med VL - 140 UR - https://doi.org/10.7326/0003-4819-140-8-200404200-00013 DO - 10.7326/0003-4819-140-8-200404200-00013 ID - Vijan2004 ER - TY - JOUR AU - Ginsberg, H. N. PY - 2006 DA - 2006// TI - REVIEW: efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia JO - J Clin Endocrinol Metab VL - 91 UR - https://doi.org/10.1210/jc.2005-2084 DO - 10.1210/jc.2005-2084 ID - Ginsberg2006 ER - TY - JOUR AU - Puccetti, L. PY - 2011 DA - 2011// TI - Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia JO - Atherosclerosis VL - 214 UR - https://doi.org/10.1016/j.atherosclerosis.2010.10.006 DO - 10.1016/j.atherosclerosis.2010.10.006 ID - Puccetti2011 ER - TY - JOUR AU - Parson, H. K. PY - 2010 DA - 2010// TI - Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes JO - Diabetes Metab Syndr Obes VL - 3 UR - https://doi.org/10.2147/DMSOTT.S8376 DO - 10.2147/DMSOTT.S8376 ID - Parson2010 ER - TY - JOUR AU - Deedwania, P. PY - 2006 DA - 2006// TI - Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study JO - Lancet VL - 368 UR - https://doi.org/10.1016/S0140-6736(06)69292-1 DO - 10.1016/S0140-6736(06)69292-1 ID - Deedwania2006 ER - TY - JOUR AU - Kostapanos, M. S. PY - 2009 DA - 2009// TI - Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose JO - Int J Clin Pract VL - 63 UR - https://doi.org/10.1111/j.1742-1241.2009.02101.x DO - 10.1111/j.1742-1241.2009.02101.x ID - Kostapanos2009 ER - TY - JOUR AU - Rizos, C. V. PY - 2010 DA - 2010// TI - Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study JO - Clin Ther VL - 32 UR - https://doi.org/10.1016/j.clinthera.2010.03.018 DO - 10.1016/j.clinthera.2010.03.018 ID - Rizos2010 ER - TY - JOUR AU - Fraulob, J. C. PY - 2012 DA - 2012// TI - Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet JO - Clin Sci (Lond) VL - 123 UR - https://doi.org/10.1042/CS20110373 DO - 10.1042/CS20110373 ID - Fraulob2012 ER - TY - JOUR AU - Cohen, D. E. AU - Anania, F. A. AU - Chalasani, N. PY - 2006 DA - 2006// TI - An assessment of statin safety by hepatologists JO - Am J Cardiol VL - 97 UR - https://doi.org/10.1016/j.amjcard.2005.12.014 DO - 10.1016/j.amjcard.2005.12.014 ID - Cohen2006 ER - TY - JOUR AU - Ridker, P. M. PY - 2012 DA - 2012// TI - Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)61190-8 DO - 10.1016/S0140-6736(12)61190-8 ID - Ridker2012 ER - TY - BOOK AU - Gajda, A. M. AU - Pellizzon, M. A. AU - Ricci, M. R. AU - Ulman, E. A. PY - 2007 DA - 2007// TI - Diet-Induced Metabolic Syndrome in Rodent Models ID - Gajda2007 ER - TY - JOUR AU - Fraulob, J. C. PY - 2010 DA - 2010// TI - A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet JO - J Clin Biochem Nutr VL - 46 UR - https://doi.org/10.3164/jcbn.09-83 DO - 10.3164/jcbn.09-83 ID - Fraulob2010 ER - TY - JOUR AU - Gallou-Kabani, C. PY - 2007 DA - 2007// TI - C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome JO - Obesity (Silver Spring) VL - 15 UR - https://doi.org/10.1038/oby.2007.238 DO - 10.1038/oby.2007.238 ID - Gallou-Kabani2007 ER - TY - JOUR AU - Reeves, P. G. AU - Nielsen, F. H. AU - Fahey, G. C. PY - 1993 DA - 1993// TI - AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet JO - J Nutr VL - 123 ID - Reeves1993 ER - TY - JOUR AU - Matthews, D. R. PY - 1985 DA - 1985// TI - Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man JO - Diabetologia VL - 28 UR - https://doi.org/10.1007/BF00280883 DO - 10.1007/BF00280883 ID - Matthews1985 ER - TY - JOUR AU - Vieira, V. J. PY - 2009 DA - 2009// TI - Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice JO - Cytokine VL - 46 UR - https://doi.org/10.1016/j.cyto.2009.03.006 DO - 10.1016/j.cyto.2009.03.006 ID - Vieira2009 ER - TY - JOUR AU - Mandarim-de-Lacerda, C. A. PY - 2003 DA - 2003// TI - Stereological tools in biomedical research JO - An Acad Bras Cienc VL - 75 UR - https://doi.org/10.1590/S0001-37652003000400006 DO - 10.1590/S0001-37652003000400006 ID - Mandarim-de-Lacerda2003 ER - TY - JOUR AU - Aguila, M. B. PY - 2003 DA - 2003// TI - Dietary effect of different high-fat diet on rat liver stereology JO - Liver Int VL - 23 UR - https://doi.org/10.1034/j.1478-3231.2003.00858.x DO - 10.1034/j.1478-3231.2003.00858.x ID - Aguila2003 ER - TY - JOUR AU - Mandarim-de-Lacerda, C. A. AU - Fernandes-Santos, C. AU - Aguila, M. B. PY - 2010 DA - 2010// TI - Image analysis and quantitative morphology JO - Methods Mol Biol VL - 611 UR - https://doi.org/10.1007/978-1-60327-345-9_17 DO - 10.1007/978-1-60327-345-9_17 ID - Mandarim-de-Lacerda2010 ER - TY - JOUR AU - Fernandes-Santos, C. PY - 2009 DA - 2009// TI - Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet JO - Nutrition VL - 25 UR - https://doi.org/10.1016/j.nut.2008.12.010 DO - 10.1016/j.nut.2008.12.010 ID - Fernandes-Santos2009 ER - TY - JOUR AU - Reagan-Shaw, S. AU - Nihal, M. AU - Ahmad, N. PY - 2008 DA - 2008// TI - Dose translation from animal to human studies revisited JO - FASEB J VL - 22 UR - https://doi.org/10.1096/fj.07-9574LSF DO - 10.1096/fj.07-9574LSF ID - Reagan-Shaw2008 ER - TY - JOUR AU - McGarry, J. D. AU - Dobbins, R. L. PY - 1999 DA - 1999// TI - Fatty acids, lipotoxicity and insulin secretion JO - Diabetologia VL - 42 UR - https://doi.org/10.1007/s001250051130 DO - 10.1007/s001250051130 ID - McGarry1999 ER - TY - JOUR AU - Sharma, A. M. AU - Engeli, S. PY - 2006 DA - 2006// TI - The role of renin-angiotensin system blockade in the management of hypertension associated with the cardiometabolic syndrome JO - J Cardiometab Syndr VL - 1 UR - https://doi.org/10.1111/j.0197-3118.2006.05422.x DO - 10.1111/j.0197-3118.2006.05422.x ID - Sharma2006 ER - TY - JOUR AU - Strissel, K. J. PY - 2007 DA - 2007// TI - Adipocyte death, adipose tissue remodeling, and obesity complications JO - Diabetes VL - 56 UR - https://doi.org/10.2337/db07-0767 DO - 10.2337/db07-0767 ID - Strissel2007 ER - TY - JOUR AU - Ren, T. PY - 2006 DA - 2006// TI - Metformin reduces lipolysis in primary rat adipocytes stimulated by tumor necrosis factor-alpha or isoproterenol JO - J Mol Endocrinol VL - 37 UR - https://doi.org/10.1677/jme.1.02061 DO - 10.1677/jme.1.02061 ID - Ren2006 ER - TY - JOUR AU - Postic, C. AU - Girard, J. PY - 2008 DA - 2008// TI - The role of the lipogenic pathway in the development of hepatic steatosis JO - Diabetes Metab VL - 34 UR - https://doi.org/10.1016/S1262-3636(08)74599-3 DO - 10.1016/S1262-3636(08)74599-3 ID - Postic2008 ER - TY - JOUR AU - Svegliati-Baroni, G. PY - 2006 DA - 2006// TI - A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury JO - Am J Pathol VL - 169 UR - https://doi.org/10.2353/ajpath.2006.050953 DO - 10.2353/ajpath.2006.050953 ID - Svegliati-Baroni2006 ER - TY - JOUR AU - Sekiya, M. PY - 2003 DA - 2003// TI - Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression JO - Hepatology VL - 38 UR - https://doi.org/10.1016/j.hep.2003.09.028 DO - 10.1016/j.hep.2003.09.028 ID - Sekiya2003 ER - TY - JOUR AU - Anderson, N. AU - Borlak, J. PY - 2008 DA - 2008// TI - Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis JO - Pharmacol Rev VL - 60 UR - https://doi.org/10.1124/pr.108.00001 DO - 10.1124/pr.108.00001 ID - Anderson2008 ER - TY - JOUR AU - Pessayre, D. PY - 2007 DA - 2007// TI - Role of mitochondria in non-alcoholic fatty liver disease JO - J Gastroenterol Hepatol VL - 22 UR - https://doi.org/10.1111/j.1440-1746.2006.04640.x DO - 10.1111/j.1440-1746.2006.04640.x ID - Pessayre2007 ER - TY - JOUR AU - Wei, Y. PY - 2008 DA - 2008// TI - Nonalcoholic fatty liver disease and mitochondrial dysfunction JO - World J Gastroenterol VL - 14 UR - https://doi.org/10.3748/wjg.14.193 DO - 10.3748/wjg.14.193 ID - Wei2008 ER - TY - JOUR AU - Ibdah, J. A. PY - 2005 DA - 2005// TI - Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance JO - Gastroenterology VL - 128 UR - https://doi.org/10.1053/j.gastro.2005.02.001 DO - 10.1053/j.gastro.2005.02.001 ID - Ibdah2005 ER - TY - JOUR AU - Brunt, E. M. PY - 1999 DA - 1999// TI - Nonalcoholic steatohepatitis (NASH): further expansion of this clinical entity? JO - Liver VL - 19 UR - https://doi.org/10.1111/j.1478-3231.1999.tb00047.x DO - 10.1111/j.1478-3231.1999.tb00047.x ID - Brunt1999 ER - TY - JOUR AU - Mu, J. PY - 2006 DA - 2006// TI - Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes JO - Diabetes VL - 55 UR - https://doi.org/10.2337/db05-1602 DO - 10.2337/db05-1602 ID - Mu2006 ER - TY - JOUR AU - Anagnostis, P. PY - 2011 DA - 2011// TI - Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study JO - Int J Clin Pract VL - 65 UR - https://doi.org/10.1111/j.1742-1241.2011.02655.x DO - 10.1111/j.1742-1241.2011.02655.x ID - Anagnostis2011 ER - TY - JOUR AU - Anagnostis, P. PY - 2011 DA - 2011// TI - Impact of statins on glucose metabolism–a matter of debate JO - Am J Cardiol VL - 107 UR - https://doi.org/10.1016/j.amjcard.2011.03.018 DO - 10.1016/j.amjcard.2011.03.018 ID - Anagnostis2011 ER -